Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Machán

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Ceskoslovenska Farmacie|September 1, 1979
[15 years of use of technetium-99m in diagnosis]S Vilcek, V Machán
Ceskoslovenska Radiologie|January 1, 1979
[Progress in the exploitation of technecium 99m in nuclear medicine in 1976 (author's transl)]S Vilcek, V Machán
Radiobiologia, Radiotherapia|January 1, 1982
99mTc-labelled compounds prepared with antimony (III) as reducing agentS Vilcek, V Machán, M Kalincák
Nuklearmedizin. Nuclear Medicine|December 1, 1981
99mTc-labelled compounds prepared with sodium dithionite as reducing agentS Vilcek, M Kalincák, V Machán
The International Journal of Applied Radiation and Isotopes|March 1, 1984
99mTc-labelled compounds prepared with molybdenum III as reducing agentS Vilcek, V Machán, M Kalincák
Ceskoslovenska Radiologie|January 1, 1978
[Advances in use technetium 99m in nuclear edicine in 1975 (author's transl)]S Vilcek, V Machán, M Kalincák
Radiobiologia, Radiotherapia|January 1, 1983
99mTc-labelled compounds prepared with antimony(III) as reducing agentS Vilcek, V Machán, M Kalincák
European Journal of Nuclear Medicine|January 1, 1980
SORB-GEL method of analysis of 99mTc-labelled compoundsV Machán, S Vilcek, M Kalincák, et al.
The International Journal of Applied Radiation and Isotopes|November 1, 1979
99mTc-Ti-DTPA: preparation, control and biological distributionS Vilcek, V Machán, M Kalincák, et al.
Casopis Lekaru Ceskych|April 30, 1981
[Acidity and chemical composition of 99mTc-radiopharmaceutics and their effect on 99mTc cummlation in the necrotic tissue of rat myocardium (author's transl)]S Vilcek, V Machán, M Kalincák, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Ceskoslovenska Farmacie|September 1, 1979
[15 years of use of technetium-99m in diagnosis]S Vilcek, V Machán
Ceskoslovenska Radiologie|January 1, 1979
[Progress in the exploitation of technecium 99m in nuclear medicine in 1976 (author's transl)]S Vilcek, V Machán
Radiobiologia, Radiotherapia|January 1, 1982
99mTc-labelled compounds prepared with antimony (III) as reducing agentS Vilcek, V Machán, M Kalincák
Nuklearmedizin. Nuclear Medicine|December 1, 1981
99mTc-labelled compounds prepared with sodium dithionite as reducing agentS Vilcek, M Kalincák, V Machán
The International Journal of Applied Radiation and Isotopes|March 1, 1984
99mTc-labelled compounds prepared with molybdenum III as reducing agentS Vilcek, V Machán, M Kalincák
Ceskoslovenska Radiologie|January 1, 1978
[Advances in use technetium 99m in nuclear edicine in 1975 (author's transl)]S Vilcek, V Machán, M Kalincák
Radiobiologia, Radiotherapia|January 1, 1983
99mTc-labelled compounds prepared with antimony(III) as reducing agentS Vilcek, V Machán, M Kalincák
European Journal of Nuclear Medicine|January 1, 1980
SORB-GEL method of analysis of 99mTc-labelled compoundsV Machán, S Vilcek, M Kalincák, et al.
The International Journal of Applied Radiation and Isotopes|November 1, 1979
99mTc-Ti-DTPA: preparation, control and biological distributionS Vilcek, V Machán, M Kalincák, et al.
Casopis Lekaru Ceskych|April 30, 1981
[Acidity and chemical composition of 99mTc-radiopharmaceutics and their effect on 99mTc cummlation in the necrotic tissue of rat myocardium (author's transl)]S Vilcek, V Machán, M Kalincák, et al.
Pageof 2